Background: Hepatitis C virus is an important cause of chronic liver disease with 71 million people worldwide living with chronic HCV infection as at 2015. Nigeria has the second largest burden of HIV in Africa, with 3.2 million Nigerians living with HIV/AIDS in 2016. Most people infected with the hepatitis C virus are asymptomatic and often unaware of their infection. This study was conducted to determine the prevalence of and risk factors for HCV and HIV infections among apparently healthy individuals in Lagos.
Introduction:
Hepatitis C virus is a hepatotropic virus well known to lead to chronic liver disease such as chronic hepatitis, liver cirrhosis and hepatocellular carcinoma. In 2015, 71 million people were estimated to be living with chronic HCV infection and the global prevalence of HCV was 1% (1). Viral hepatitis was said to be responsible for 1.3 million deaths in 2015. Worldwide, 2.3 million persons living with HIV were also infected with hepatitis C virus. The burden of hepatitis constitutes a global public threat which made the World health assembly in 2016 to approve a global strategy for the elimination of viral hepatitis by the year 2030 (3). Therefore if people living with hepatitis b and hepatitis c infection are not diagnosed and treated, the number of deaths will continue to rise (1).
In 2016, the prevalence rate of HIV infection in Nigeria was 2.9% which translates into 3.2 million people living with HIV/AIDS. There were 220,000 new HIV infections and an estimated 160,000 adult and children died of AIDS (2).
The prevalence of hepatitis C in Nigeria from a population based screening is 0.9% (4). In Nigeria, its prevalence is higher among populations at high risk such as patients who are positive for the human immuno deficiency virus with 2.3% (5), mentally ill individuals 12.6% (6), intravenous drug users 7.7% (7) and patients with sickle cell anaemia 5% (8).
Most people with chronic HCV infections are asymptomatic and those infected most often have no knowledge of their infection. Testing for HCV is poor as shown in a 2015 study by the World health organisation that reported that only 20% of those living with HCV infection knew their status (1). In Nigeria only 34% of people living with HIV infection know their status (2). Therefore testing for both HIV and HCV is very important to know the burden of infection and know those who need to access care and treatment.
One of the strategies for the elimination of viral hepatitis is testing and treatment. Most of the studies on hepatitis C in Nigeria have tested few individuals and subgroups of the population. This study was conducted to determine the prevalence and risk factors of HCV and HIV among apparently healthy individuals in Lagos from data collected from a health screening programme.
Materials and methods: Study design
This was a retrospective study to determine the prevalence of hepatitis C virus antibodies and HIV among apparently healthy individuals who presented for health screening from May 2014 to June 2016 at a private medical diagnostic centre in Lagos. The health records of those who met the inclusion criteria were systematically reviewed to extract the demographic and clinical information including age, sex, history of blood transfusion, alcohol use, surgery and results of serum liver enzymes and serological tests for antibodies to hepatitis C virus and HIV. The detail of the identity of the subjects was kept confidential with all identifiers removed except for the demographic and clinical information mentioned above.
The centre is a leading medical diagnostic centre in Lagos state. It has a health assessment clinic with different health check-up plans consisting of a range of laboratory and radiological tests and clinical examination to detect lifestyle diseases early (when chances of treatment and cure are better) or prevent their occurrence.
The eligibility criteria included individuals aged 18 years and above who registered for health check-up plans within the study period that included screening tests for Hepatitis C virus antibody or HIV.
Laboratory procedures
Antibody to Hepatitis C virus was tested on samples collected from the clients using the Roche Elecsys HCV Antibody (Roche Diagnostics Ltd, Mannheim, Germany) assay. This is an electrochemiluminescence immunoassay "ECLIA" performed on Cobas e 411 immunoassay analyser. Antibodies to Human immunodeficiency virus were tested for using the Alere Determine HIV 1/2 test kit (Alere, USA). The tests were done according to manufacturer's instructions.
Ethical approval was obtained from the Lagos University Teaching Hospital Health Research and ethics committee.
Data analysis
Data was analysed using SPSS version 20. Discrete variables were analysed using the Chi-square test while Student's t-test was used to evaluate differences between means. Odds ratio (OR) was used as a measure of the strength of association and p value <0.05 was be considered statistically significant.
Results: Sociodemographic characteristics of study participants
Out of 1379 apparently healthy individuals included in the study, over half of them were male (829, 60.1%). Of the 1379 participants, 1356 individuals were tested for hepatitis C antibody, 1280 individuals tested for HIV. The mean age was 47.1 ± 12 years and 795 (57.6%) of them were in the age group 31 -50 years. There was no significant difference between the mean ages of male (47.5 ± 11.7 years) and females (46.6 ± 12.4 years). Majority (1190, 87.4%) of the participants were married, while 8.8% were single. Most of the participants had no history of blood transfusion (1318, 95.6%) or prior history of surgery (987, 71.6%), see Table 1 . 
Prevalence of hepatitis C virus
The prevalence of hepatitis C virus (HCV antibody) was 0.7% (n=9, 95% CI 0. 
Risk factors for hepatitis C virus infection
In the bivariate analysis, 0.7% of 
Prevalence of HIV
In this study, the prevalence of HIV was 2% (n = 25, 95% CI 1.3 -2.7%). The prevalence of HIV in females was 1.2% and 2.5% in males. The Table 3 ).
Discussion:
This study represents the results of health screening for hepatitis C virus infection and HIV in asymptomatic Nigerians. The prevalence of HCV in this study was low at 0.7%. This is similar to findings of 0.4% among University under-graduates in Ogbomoso (9), a population based screening in Lagos 0.9% (4), and among first time blood donors in Abeokuta 1.5% (10). It is also similar to findings in studies from other African countries such as Eritrea 0.7%, Somalia 0.9% and Sudan 1% (11 -12).
However, the prevalence of HCV antibody in this study is lower than that reported among healthy blood donors in Port Harcourt 5%, Calabar 10%, a rural population in Cameroon 6.3% and the WHO estimated African regional HCV prevalence of 5.3% (13 -16). The differences in prevalence across the studies may be due to differences in demographics, socioeconomic status, risk behaviour, and the method of testing employed. The low prevalence in this study may also be due to the fact that the subjects live in Lagos which is an urban area, because the prevalence of HCV has been reported to be higher in rural versus urban areas (17) .
The prevalence of HIV infection in this study was found to be 2%, which is similar to studies from Burkina Faso with 1.8%, and Tanzania 2.2% (18, 19) . It is lower than the Nigerian national prevalence of 2.9% (2), other studies from Nigeria such as 3.1% from Osogbo (20) 
Many studies have demonstrated co-infection with the hepatitis C virus and HIV. However, no co-infection was demonstrated in this study, and this is similar to other studies from Benin-city and Ethiopia (24 -25) . In this study, older age was not found to be a risk factor for hepatitis C virus infection as it has been previously described. Those who were 30 years or younger had the highest prevalence of HCV antibody but age was not statistically significant. Males had a higher rate of HCV infection in this study but gender was not a significant risk factor. Unsafe blood supply has contributed to HCV transmission in developing countries but in this study previous history of blood transfusion was not significantly associated with risk of HCV infection. Marital status, previous history of surgery, and alcohol use, were not significantly associated with the risks of HCV infection. In as many as one third of subjects with HCV, a risk factor could not be identified for their infection (26 -28) .
In this study, those with no previous history of surgery were 5 times more likely to be infected with HIV. No history of previous history of surgery was significantly associated with the risk of HIV infection. This is surprising because surgical procedures which are invasive offer opportunity for transmission of HIV through poor infection control practices such as use of contaminated surgical instruments, equipment and injections. It may also be due to a cofounding factor. The reason for this is not clear. Transfusion of infected blood and blood products contribute to transmission of HIV infection and these products are routinely screened for HIV. However, prior history of blood transfusion was not significantly associated with risk of HIV infection in this study.
The highest rate of HIV was found in subjects younger than 30 years, as is reported in other studies however age was not significantly associated with the risk of HIV infection. Noteworthy is our finding that the highest rates of HIV occurred in those who had been previously married (divorced or separated or widowed) even though this was not statistically significant. Men were 2 times more likely to be HIV infected in this study but gender was not significantly associated with HIV infection in this study. Some studies have shown that women have significantly higher HIV prevalence rates than men across countries and age groups (29) .
In conclusion, this study among apparently healthy Nigerians shows that prevalence rates of HCV and HIV were lower than earlier documented and there was no documented HCV-HIV coinfection. Previous history of surgery was the only significant risk factor for HIV infection. Screening of healthy individuals for HIV and HCV infection is very important to determine those who are infected and therefore need to access treatment. 
